Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Issue: Health products
Clear all
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 14 of 14 items.
… with English-only Labels for Use in Relation to the COVID-19 Pandemic Starting date: July 30, 2021 Posting date: July … Sale and Advertising of Drugs for Use in Relation to COVID-19 . Casirivimab and imdevimab, to be administered …
AlertHealth professional risk communication | 2021-07-30
… authorized VEKLURY® (remdesivir) with conditions to treat COVID-19 in adults and adolescents with pneumonia requiring … of VEKLURY (remdesivir) worldwide, as a result of the COVID-19 pandemic. VEKLURY is the first drug that Health …
AlertHealth professional risk communication | 2020-09-15
… Archived – Medication Errors Involving Reminyl and Amaryl – Janssen-Ortho Inc. and Aventis Pharma Inc. Starting date: … Images This is duplicated text of a letter from Janssen-Ortho Inc. & Aventis Pharma Inc. Contact the company … Directorate at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, OntarioM3C 1L9 Call toll-free at …
AlertHealth professional risk communication | 2004-12-21
… Archived – Medication Errors Involving Reminyl and Amaryl –Janssen-Ortho Inc. and Aventis Pharma Inc. Starting date: … Images This is duplicated text of a letter from Janssen-Ortho Inc. & Aventis Pharma Inc. Contact the company … Directorate at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, Ontario M3C 1L9 Call toll-free …
AlertHealth professional risk communication | 2004-12-21
… blocker (NMB) products in Canada as a result of the COVID-19 pandemic. Pancuronium Bromide Injection, USP is a … blocker (NMB) products in Canada as a result of the COVID-19 pandemic. Pancuronium Bromide Injection, USP is a …
AlertHealth professional risk communication | 2020-04-29
… Rocuronium Bromide Injection in Canada as a result of the COVID-19 pandemic. Rocuronium Bromide Injection is a … Rocuronium Bromide Injection in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this …
AlertHealth professional risk communication | 2020-05-25
… Reactions – For the Public Starting date: October 19, 2009 Posting date: October 19, 2009 Type of … is duplicated text of a letter from Tibotec, a division of Janssen-Ortho Inc . Contact the company for a copy of any … Severe Skin and Allergic Reactions Tibotec, a division of Janssen-Ortho Inc. ("Tibotec"), in collaboration with Health …
AlertHealth professional risk communication | 2009-10-19
… – Medication Errors Involving REMINYL and AMARYL® – Janssen-Ortho Inc. and Aventis Pharma Inc. Starting date: … RA-19000210 This is duplicated text of a letter from Janssen-Ortho Inc. and Aventis Pharma Inc. Contact the … Canada at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, Ontario M3C 1L9 Or call toll …
AlertHealth professional risk communication | 2004-12-21
… chloride injection USP) in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this product, … chloride injection USP) as a result of the COVID-19 pandemic. A limited quantity of US-labelled QUELICIN …
AlertHealth professional risk communication | 2020-04-29
… Adverse Events in Placebo-Controlled Dementia Trials – Janssen-Ortho Inc. Starting date: October 11, 2002 Posting … RA-17000390 This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … USA-63 1% (5/462) 1% (2/163) BEL-14 0% (0/20) 0% (0/19) Total 4% (29/764) 2% (7/466) Four patients died in the …
AlertHealth professional risk communication | 2002-10-11
… Regarding Higher than Normal Blood Acid Levels – Janssen-Ortho Inc. – For the Public Starting date: January … RA-19000220 This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … than Normal Blood Acid Levels Toronto, January 20, 2004 - Janssen-Ortho, following discussions with Health Canada, is …
AlertHealth professional risk communication | 2004-01-26
… neuromuscular blocker (NMB), in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this product, … Rocuronium Bromide Injection in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this …
AlertHealth professional risk communication | 2020-04-29
… Canada of Rocuronium Bromide Injection as a result of the COVID-19 pandemic. Rocuronium Bromide injection is a … Rocuronium Bromide Injection in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this …
AlertHealth professional risk communication | 2020-05-25
… for Cisatracurium Besylate Injection as a result of the COVID-19 pandemic. Cisatracurium Besylate Injection is a … for Cisatracurium Besylate Injection, as a result of the COVID-19 pandemic. Given the medical necessity of this …
AlertHealth professional risk communication | 2020-05-25